Seaweed – The Superfood Tackling Health Emissions And Food Security
As the world battles rising chronic disease and climate instability, seaweed is emerging as a rare solution to both. Once relegated to coastal cuisines, this fast-growing marine macroalgae is now surfacing in dietary supplements, snacks, bioplastics and even methane-reducing livestock feed.
Seaweed has emerged as a promising solution to help meet global food and material demands without expanding agricultural land. Researchers from institutions including the University of Queensland, International Institute for Applied Systems Analysis, and Commonwealth Scientific and Industrial Research Organization found that scaling up the cultivation of commercially valuable seaweed species could significantly ease pressure on terrestrial farming. These findings underscore seaweed's potential to support both food security and climate goals, provided land and ocean resources are managed in an integrated, sustainable way.
According to a Science Direct article, Western diets are deficient in fiber and essential micronutrients, contributing to gut imbalances, chronic inflammation, and metabolic dysfunction. Seaweed, particularly sugar kelp, naturally fills these gaps with a potent mix of insoluble fibers such as fucoidan, beta-glucan, alginate, and cellulose. When fermented by gut bacteria, these fibers produce short-chain fatty acids, compounds linked to improved insulin sensitivity, satiety, and immune health.
TOPSHOT - Captain John Lovett, 52, uses a knife to harvest kelp and throws keepers into a large bin ... More on the boat in Duxbury, Massachusetts on May 9, 2023. (Photo by Joseph Prezioso / AFP) (Photo by JOSEPH PREZIOSO/AFP via Getty Images)
Seaweed Health Support From The Ocean
OCEANIUM, a UK-based biotech founded by Karen Scofield Seal and Dr. Charlie Bavington, is using seaweed to support both people and planet. Their flagship product, OCEAN ACTIVES® H+, delivers a clinically proven 250 mg dose that improves the ratio of beneficial to harmful gut bacteria, specifically increasing Bifidobacterium while decreasing Enterobacteriaceae.
The company's proprietary green biorefinery process ensures their ingredients are bioavailable, food-safe, and traceable from sea to shelf. OCEANIUM is also collaborating with Wageningen University on dementia-prevention research through the gut-brain axis and working with Reading University to explore human and pet nutrition.
From a sustainability standpoint, seaweed requires no land, freshwater, or fertilizer, making it one of the most sustainable crops on Earth. According to the company, it supports six UN Sustainable Development Goals, absorbs CO₂ and nitrogen, and increases marine biodiversity.
OCEANIUM is not alone in the innovation game. PhycoHealth in Australia produces seaweed-based capsules targeting gut and skin health. FutureFeed, another Australian agritech company, has developed a seaweed-based cattle feed supplement that cuts methane emissions by over 80%, according to CSIRO.
Challenges Facing Seaweed And The Way Forward
Despite its potential, seaweed still faces hurdles to mainstream adoption. Limited processing infrastructure poses a bottleneck to scaling, and its taste and texture can be off-putting to some consumers. According to the OCEANIUM team, overcoming these challenges requires offering products in familiar, easy-to-use formats with a neutral flavor profile. Their approach focuses on refining seaweed into versatile ingredients that seamlessly integrate into everyday foods like snacks, soups, and protein bars. Just as crucial is consumer education, emphasizing seaweed's health benefits and sustainability value to build trust and encourage widespread use.
Pills of seaweed spirulina, chlorella on a wooden spoon close up. Vegetarian Super food with plant ... More protein
Seaweed is no longer a fringe ingredient, it is a frontier crop with the potential to nourish people and regenerate the planet. Backed by science, powered by innovation, and aligned with global sustainability goals, seaweed offers a rare convergence of health, climate, and economic opportunity. Seaweed brands are proving that with smart processing, strategic partnerships, and consumer education, seaweed can transcend its niche and become a mainstream force in food systems, bioeconomy, and environmental resilience. The path forward isn't without obstacles, but if cultivated with care, this marine resource could help reshape the future of both nutrition and planetary stewardship.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
7 hours ago
- Medscape
More Sit-to-Stand Transitions Benefit Postmenopausal Women
TOPLINE: Reducing sedentary behavior with interventions such as increasing daily sit-to-stand transitions might help lower blood pressure in postmenopausal women with overweight or obesity. METHODOLOGY: Researchers conducted a randomized controlled trial to assess how different strategies to reduce time spent sitting affected the physiologic responses of postmenopausal women who led sedentary lives. The researchers included 407 women in the postmenopausal phase (mean age, 68 years; 92% White) who had overweight or obesity (average BMI, 32), had a sitting time of at least 7 hours a day, and performed no more than 70 sit-to-stand transitions daily. The women were randomly assigned to one of three study arms: healthy living (n = 135), sit less (n = 136), and increased sit-to-stand transitions (n = 136). All arms received seven sessions of individual health coaching over 12 weeks. Researchers assessed blood pressure and markers of glucose regulation using fasting blood samples. Readings from thigh- and hip-worn accelerometers for 7 days were used to evaluate posture, sedentary behavior, and physical activity. Primary outcomes were measurements of glucose regulation and resting blood pressure at baseline and 3 months. TAKEAWAY: A total of 388 women completed the trial, with no serious adverse events related to the study. Participants in the sit-less arm had a daily sitting time of approximately 58 minutes less than those in the healthy-living arm (P < .001), whereas those in the sit-to-stand arm had 26 more sit-to-stand transitions daily (P < .001). Diastolic blood pressure fell by 2.24 mm Hg in the sit-to-stand arm compared with the healthy living arm (P = .02); the decrease in systolic blood pressure did not reach a predefined significance level. Compared with the healthy-living arm, neither intervention produced significant changes in markers of glucose regulation. IN PRACTICE: 'Postmenopausal women are at high risk of engaging in large amounts of sitting time and cardiovascular diseases. The present randomized controlled trial adds to existing evidence by demonstrating that within just 3 months, increasing' sit-to-stand transitions can lower diastolic blood pressure, the researchers wrote. SOURCE: This study was led by Sheri J. Hartman, PhD, University of California, San Diego. It was published online on July 25, 2025, in Circulation. LIMITATIONS: The generalizability of findings was limited by the lack of ethnic and racial diversity. The 3-month intervention period may have been too brief to observe sizeable physiologic changes. Measurement of only fasting glucose parameters could not capture changes after meals. DISCLOSURES: This study received support from the National Institute of Aging. Additional support was provided by the Altman Clinical & Translational Research Institute at the University of California, San Diego, funded by the National Center for Advancing Translational Sciences. The authors did not report any conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Fox News
7 hours ago
- Fox News
Leading 'biohacker' reveals why RFK Jr.'s health crusade 'couldn't come at a better time'
"Biohacker" Gary Brecka has healed names like UFC's Dana White, and now he's supporting RFK, Jr.'s MAHA mission to heal others. The human biologist notorious for claims like "humans could soon live up to 150 years" joined "Fox & Friends" on Monday to enthuse about the HHS secretary's push to stifle the chronic disease epidemic sweeping the U.S. "Bobby Kennedy's mission to make America healthy again couldn't come at a better time," Brecka told guest host Sandra Smith. "America is the sickest, fattest, most disease-ridden nation in the world and spends nearly $5 trillion a year on healthcare. And there are a lot of scary initiatives that are working their way through Congress right now and have worked their way to Congress in the past that are really not a service to American families, farmers, and our workers — and we're putting the needs and the interests of chemical companies before the needs of our citizens, and I think it's finally coming to an end." Brecka – a longevity expert who helps optimize human performance – believes the COVID-19 pandemic "rattled" the cages of many around the world who, for the first time, realized the importance of taking their healthcare choices into their own hands. At that same time, he believes Americans are growing increasingly aware of what contributes to chronic illness. "People are becoming citizen scientists… We're actually becoming more aware of what's going on in the United States and around the world that's making us sick," he said. Chemical companies seeking broad immunity for products that allegedly cause harm such as infertility, cancer or neurological issues is but one issue Brecka sounded the alarm on. He also preached to viewers that food and movement are medicine, and returning to whole, unprocessed foods ranks high among the key secrets to living a longer, healthier and more fulfilling life. "When I was a mortality researcher, we realized that the reason why most people are not living longer, healthier, happier lives — more fulfilling lives — was because of what we called modifiable risk factors – things like movement, sunlight, grounding, connection, sense of community, sense of purpose, reconnecting with nature, reconnecting with each other," he said. "Food is medicine, movement is medicine, and I think the MAHA movement, no pun intended, is really getting this message to the American people." Many companies have agreed to slash artifical dyes, swap seed oils for beef tallow and offer options with alternative ingredients amid the MAHA movement's calls for change. Most recently, Coca-Cola agreed to offer an option of its classic formula containing cane sugar in place of high-fructose corn syrup. Frito-Lay, a subsidiary of PepsiCo, agreed to remove artificial colors from popular food items by the end of 2025. And fast food franchise Steak 'N' Shake swapped vegetable oils for beef HERE TO JOIN FOX NATIONFox Nation subscribers can hear more from Gary Brecka by streaming his interview with Sean Hannity.
Medscape
7 hours ago
- Medscape
Hydroxychloroquine Use May Be Beneficial in Lupus Nephritis
TOPLINE: Hydroxychloroquine exposure in patients with lupus nephritis was associated with a substantially lower risk for estimated glomerular filtration rate (eGFR) decline of ≥ 30%, particularly among those with chronic kidney disease (CKD) stage ≥ 3. METHODOLOGY: Researchers conducted a retrospective study involving 209 patients with biopsy-proven incident lupus nephritis (mean age at diagnosis, 38 years; 75% women) between 1994 and 2019 identified at a single center in Wisconsin to examine the effect of hydroxychloroquine on kidney function. Hydroxychloroquine exposure status (median dose, > 5 vs ≤ 5 mg/kg/d) was determined at each visit using electronic health records, with positive exposure ascertained by an active prescription for at least 3 months at each follow-up. The primary outcome was eGFR decline of ≥ 30% at a minimum of two follow-up visits compared with baseline eGFR, or the requirement of sustained renal replacement therapy, with a mean follow-up duration of 5.4 years. The secondary outcome included an eGFR decline of ≥ 40%, and the annual eGFR slope to assess kidney function decline over time. TAKEAWAY: Time-varying exposure to hydroxychloroquine was associated with a 59% lower risk for an eGFR decline of ≥ 30% (adjusted hazard ratio [aHR], 0.41; P = .007). Similarly, hydroxychloroquine exposure was associated with a 66% lower risk for an eGFR decline of ≥ 40% (aHR, 0.34; P = .004). In patients with CKD stage ≥ 3 at lupus nephritis diagnosis, hydroxychloroquine exposure was associated with a 77% lower risk for an eGFR decline of ≥ 30% (aHR, 0.23; P = .03). Exposure to hydroxychloroquine led to significant annual reductions in eGFR slope declines of 5.12 mL/min/1.73 m2 within 5 years of a lupus nephritis diagnosis and 3.17 mL/min/1.73 m2 within 10 years. IN PRACTICE: 'These findings emphasize the importance of starting early and continuing HCQ [hydroxychloroquine] therapy to preserve kidney health alongside overall disease control even if SLE [systemic lupus erythematosus] is limited to the kidneys [lupus nephritis],' the authors of the study wrote. SOURCE: This study was led by Shivani Garg, MD, PhD, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin. It was published online on July 20, 2025, in Arthritis Care & Research. LIMITATIONS: The single academic institution setting potentially affected population representation. Data on hydroxychloroquine blood levels were unavailable to assess adherence and absorption variability. Decline of eGFR may have been missed in patients lost to follow-up or those who died at outside institutions. DISCLOSURES: This study received support from the University of Wisconsin-Madison, Institute for Clinical and Translational Research and the Clinical and Translational Science Award program from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences. One author reported receiving funding through the NIH and honoraria for presentation at a conference. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
